Groen H - Search Results

1

Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment.

Heuvers ME, Aerts JG, Cornelissen R, Groen H, Hoogsteden HC, Hegmans JP. Heuvers ME, et al. Among authors: groen h. BMC Cancer. 2012 Dec 5;12:580. doi: 10.1186/1471-2407-12-580. BMC Cancer. 2012. PMID: 23217146 Free PMC article. Review.

2

Continuous carboplatin infusion during 6 weeks' radiotherapy in locally inoperable non-small-cell lung cancer: a phase I and pharmacokinetic study.

Groen HJ, van der Leest AH, de Vries EG, Uges DR, Szabó BG, Mulder NH. Groen HJ, et al. Br J Cancer. 1995 Oct;72(4):992-7. doi: 10.1038/bjc.1995.448. Br J Cancer. 1995. PMID: 7547255 Free PMC article. Clinical Trial.

3

Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancer.

Groen HJ, Smit EF, Haaxma-Reiche H, Postmus PE. Groen HJ, et al. Eur J Cancer. 1993;29A(12):1696-9. doi: 10.1016/0959-8049(93)90107-q. Eur J Cancer. 1993. PMID: 7691116

4

Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.

Groen HJ, Sleijfer S, Meijer C, Kampinga HH, Konings AW, De Vries EG, Mulder NH. Groen HJ, et al. Br J Cancer. 1995 Dec;72(6):1406-11. doi: 10.1038/bjc.1995.522. Br J Cancer. 1995. PMID: 8519652 Free PMC article.

5

Phase I study of high-dose epirubicin and vinorelbine in previously untreated non-small-cell lung cancer stage IIIB-IV.

Bakker M, Groen HJ, Smit EF, Smeets J, Riggi M, Postmus PE. Bakker M, et al. Among authors: groen hj. Br J Cancer. 1995 Dec;72(6):1547-50. doi: 10.1038/bjc.1995.545. Br J Cancer. 1995. PMID: 8519675 Free PMC article. Clinical Trial.

6

A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer.

Smit EF, Fokkema E, Biesma B, Groen HJ, Snoek W, Postmus PE. Smit EF, et al. Among authors: groen hj. Br J Cancer. 1998;77(2):347-51. doi: 10.1038/bjc.1998.54. Br J Cancer. 1998. PMID: 9461009 Free PMC article. Clinical Trial.

7

Effects of gemcitabine on renal function in patients with non-small cell lung cancer.

Gietema JA, Groen HJ, Meijer S, Smit EF. Gietema JA, et al. Among authors: groen hj. Eur J Cancer. 1998 Jan;34(1):199-202. doi: 10.1016/s0959-8049(97)00354-7. Eur J Cancer. 1998. PMID: 9624259

8

A Phase II study of gemcitabine in patients with malignant pleural mesothelioma. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.

van Meerbeeck JP, Baas P, Debruyne C, Groen HJ, Manegold C, Ardizzoni A, Gridelli C, van Marck EA, Lentz M, Giaccone G. van Meerbeeck JP, et al. Among authors: groen hj. Cancer. 1999 Jun 15;85(12):2577-82. doi: 10.1002/(sici)1097-0142(19990615)85:12<2577::aid-cncr13>3.3.co;2-j. Cancer. 1999. PMID: 10375105 Clinical Trial.

9

Lack of nephrotoxicity of new oral platinum drug JM216 in lung cancer patients.

Fokkema E, de Vries EG, Meijer S, Groen HJ. Fokkema E, et al. Among authors: groen hj. Cancer Chemother Pharmacol. 2000;45(1):89-92. doi: 10.1007/PL00006749. Cancer Chemother Pharmacol. 2000. PMID: 10647508

10

First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial.

Wachters FM, Van Putten JW, Kramer H, Erjavec Z, Eppinga P, Strijbos JH, de Leede GP, Boezen HM, de Vries EG, Groen HJ. Wachters FM, et al. Among authors: groen hj. Br J Cancer. 2003 Oct 6;89(7):1192-9. doi: 10.1038/sj.bjc.6601283. Br J Cancer. 2003. PMID: 14520444 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

822 results

Search Page

Filters